Press release
Gastroesophageal Reflux Disease Therapeutics Global Market Analysis, Trends, Growth, Research And Forecast 2033
Gastroesophageal Reflux Disease Therapeutics Global Market
The Business Research Company offers in-depth market insights through Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The gastroesophageal reflux disease therapeutics market size has grown steadily in recent years. It will grow from $5.78 billion in 2023 to $6 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to changing lifestyles and dietary habits, aging population, increased awareness and diagnosis, prevailing stressful lifestyles, rise in obesity rates..
The gastroesophageal reflux disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rise in demand for novel therapies, growing geriatric population, personalized medicine approaches, focus on non-pharmacological interventions, emergence of biologics and innovative therapies.. Major trends in the forecast period include alternative therapies and mind-body practices, expanded research into gut health, advent of patient-centric care models, targeted marketing for gerd awareness, integration of digital health tools..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12058&type=smp
Market Segmentation:
The gastroesophageal reflux disease therapeutics market covered in this report is segmented -
1) By Type: Branded, Generic
2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets
4) By Application: Crohn's Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis
Major Driver - Surge In Gastroesophageal Reflux Disease Anticipated To Drive The Growth Of The Gastroesophageal Reflux Disease Therapeutics Market
The prevalence of gastroesophageal reflux disease is expected to propel the growth of the gastroesophageal reflux disease therapeutics market moving forward. Gastroesophageal reflux disease is a chronic condition characterized by the backflow of stomach acid into the esophagus, causing symptoms such as heartburn, regurgitation, and potential complications. The gastroesophageal reflux disease (GERD) therapeutics help in reducing and managing the symptoms of acid reflux by neutralizing the pH of the gut, controlling inflammation, and improving esophageal function. For instance, in September 2022, according to the article published by WebMed, a US-based online publisher of news and information about human health, more than 60 million American adults suffer heartburn at least once a month, and more than 15 million suffer daily. Furthermore, in July 2022, statistics shared by the National Library of Medicine, a US-based federal medical library, GERD is one of the most often diagnosed digestive illnesses in the United States, with a 20% prevalence, resulting in a significant economic burden in direct and indirect expenditures as well as a negative impact on quality of life. Therefore, the prevalence of gastroesophageal reflux disease is expected to drive the growth of the gastroesophageal reflux disease therapeutics market.
Competitive Landscape:
Major companies operating in the gastroesophageal reflux disease therapeutics market report are Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca plc, Medtronic PLC, GlaxoSmithKline plc, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, bioMerieux SA, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories Ltd., Bruker Corp, Amneal Pharmaceuticals LLC, CHEPLAPHARM Arzneimittel GmbH, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., EndoGastric Solutions, RaQualia Pharma Inc, TWi Pharmaceuticals Inc., Astellas Pharma Inc., SFJ Pharmaceuticals Group, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Addex Pharmacetuicals.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report
Top Trend - Innovative Medications To Reshape The Gastroesophageal Reflux Disease Therapeutics Market
Product innovations are the key trend gaining popularity in the gastroesophageal reflux disease therapeutics market. Major companies operating in the gastroesophageal reflux disease therapeutics market are focusing on innovative medications to sustain their position in the market. For instance, in March 2021, Xiromed LLC, a US-based integrated generic company, launched Omeprazole Delayed-Release Capsules (generic to Prilosec) to treat frequent heartburn in gastroesophageal reflux. Omeprazole is a proton pump inhibitor (PPI) medication designed to treat some stomach and esophageal issues (such as acid reflux and ulcers) by lowering the quantity of acid produced by the stomach that alleviating symptoms such as heartburn, trouble swallowing, and persistent cough. This drug helps cure acid damage to the stomach and esophagus, prevents ulcers, and may help prevent oesophageal cancer.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Gastroesophageal Reflux Disease Therapeutics Market Characteristics
3. Gastroesophageal Reflux Disease Therapeutics Market Trends And Strategies
4. Gastroesophageal Reflux Disease Therapeutics Market - Macro Economic Scenario
5. Gastroesophageal Reflux Disease Therapeutics Market Size And Growth
…..
27. Gastroesophageal Reflux Disease Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroesophageal Reflux Disease Therapeutics Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3429652 • Views: …
More Releases from The Business research company
2024 Global Type 2 Diabetes Market Size, Share, Trends And Growth Analysis Repor …
"The type 2 diabetes market size has grown strongly in recent years. It will grow from $44.56 billion in 2023 to $48.14 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to lifestyle and dietary changes, aging population, pharmaceutical developments, public health initiatives.
The type 2 diabetes market size is expected to see strong growth in the…
Global Esophageal Dysphagia Market 2024 : SWOT Analysis Of Key Driving Factors F …
"The esophageal dysphagia market size has grown strongly in recent years. It will grow from $1.96 billion in 2023 to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to aging population, gastroesophageal reflux disease (gerd), advances in endoscopy, esophageal motility testing.
The esophageal dysphagia market size is expected to see strong growth in the next…
Osteoarthritis Market 2024 Analysis By Size, Share, Growth, Trends Up To 2033 | …
"The osteoarthritis market size has grown rapidly in recent years. It will grow from $6.24 billion in 2023 to $6.87 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to aging population, obesity epidemic, advances in imaging, pain management.
The osteoarthritis market size is expected to see strong growth in the next few years. It will grow…
Global Caps And Closures Market 2024 : Trends, Business Growth And Major Driving …
"The caps and closures market size has grown strongly in recent years. It will grow from $73.17 billion in 2023 to $77.46 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to consumer packaging trends, food and beverage industry growth, pharmaceutical packaging needs, environmental concerns.
The caps and closures market size is expected to see strong growth…
More Releases for Gastroesophageal
Gastroesophageal Reflux Disease Therapeutics Market
As per the research conducted by GME, the Global Gastroesophageal Reflux Disease Therapeutics Market will grow with a CAGR value of 4.1%. During the forecasted timeframe, the gastroesophageal reflux disease market is likely to be sustained by a rise in the number of patients being treated for gastroesophageal reflux disease and long-term anti-reflux conservation therapy.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC…
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry.
The Gastroesophageal Reflux…
Gastroesophageal Reflux Disease Treatment Devices Market – Global Industry Ins …
Gastroesophageal refers to the stomach and esophagus. Reflux means to return or flow back. Gastroesophageal reflux disease or GERD is a set of conditions, where the lower esophageal sphincter (LES) is affected when the contents of the stomach flows back to the esophagus. In usual digestion process, the lower esophageal sphincter unfastens to let food to pass into stomach and shuts to prevent acidic stomach juices and food from going…
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market - Trends, Outloo …
Gastroesophageal refers to the stomach and esophagus. Reflux means to return or flow back. Gastroesophageal reflux disease or GERD is a set of conditions, where the lower esophageal sphincter (LES) is affected when the contents of the stomach flows back to the esophagus. In usual digestion process, the lower esophageal sphincter unfastens to let food to pass into stomach and shuts to prevent acidic stomach juices and food from going…
Growing Demand in Gastroesophageal Reflux Disease Therapeutics Market Clinical R …
Gastroesophageal Reflux Disease Therapeutics Market report is loaded with point by point analysis from an exhaustive research, particularly on questions that verge on market size, improvement condition, modern advancements, operation circumstance, pathways and pattern of Gastroesophageal Reflux Disease Therapeutics. All these are offshoots of understanding the present circumstance that the business is in, particularly in 2018. The will outline the course for a more complete organization and discernment of the…
Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2017”. In this report, the global Gastroesophageal Reflux Disease Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request For Sample Report:…
